4-氟-2-(甲氨基)苯甲酸 | 128992-62-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氟-2-(甲氨基)苯甲酸
• 英文名称: 4-fluoro-N-methylanthranilic acid
• 英文别名: 4-fluoro-2-methylamino-benzoic acid；4-Fluoro-2-(methylamino)benzoic acid
• CAS: 128992-62-1
• 化学式: C₈H₈FNO₂
• mdl: MFCD11054083
• 分子量: 169.155
• InChiKey: NKTZRZBSADJAJL-UHFFFAOYSA-N

物化性质

• 沸点：
  313.6±32.0 °C(Predicted)
• 密度：
  1.346±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 储存条件：
  室温

反应信息

• 作为反应物：
  描述：

  4-氟-2-(甲氨基)苯甲酸 在 哌啶 、 sodium hydride 、 sodium carbonate 、 溶剂黄146 作用下， 以 水 、 甲苯 为溶剂， 反应 23.0h， 生成 氟司喹南
  参考文献：
  名称：

  Birch, Alan M.; Davies, Roy V.; Maclean, Lachlan, Journal of the Chemical Society. Perkin transactions I, 1994, # 4, p. 387 - 392

  摘要：

  DOI：
• 作为产物：
  描述：

  2-氨基-4-氟苯甲酸 在 palladium on charcoal 聚合甲醛 、 氢气 作用下， 以 溶剂黄146 为溶剂， 生成 4-氟-2-(甲氨基)苯甲酸
  参考文献：
  名称：

  5-fluoroanthranilic fungicides

  摘要：

  式I的化合物##STR1##其中A为OH，B为H，C.sub.1-4烷基，可选择由C.sub.1-4烷氧羰基、C.sub.2-4烯基、CONR.sub.2或COR.sub.4取代，C为H，R.sub.2为C.sub.1-4烷基，R.sub.4为C.sub.1-4烷基或苯基，可选择由羧基取代，具有杀虫剂和特别是杀菌活性。许多这些化合物是新颖的，这些化合物本身构成了该发明的一部分。

  公开号：

  US05093364A1

文献信息

• Substituted Oxadiazole Derivatives as Positive Allosteric Modulators of Metabotropic Glutamate Receptors
  申请人：Farina Marco

  公开号：US20090215822A1

  公开（公告）日：2009-08-27

  The present invention relates to new compounds which are Oxadiazole derivatives of formula (I) wherein B, P, Q, W, R 1 and R 2 are defined in the description. Invention compounds are useful in the prevention or treatment of central or peripheral nervous system disorders as well as other disorders modulated by mGluR5 receptors.(I).

  本发明涉及一种新化合物，其为式(I)的噁二唑衍生物，其中B、P、Q、W、R1和R2在描述中有定义。该发明化合物在预防或治疗中枢或外周神经系统疾病以及其他受mGluR5受体调节的疾病方面具有用途。(I)。
• Selected Benzofuran Derivatives
  申请人：Greiveldinger-Poenaru Sorana

  公开号：US20080108610A1

  公开（公告）日：2008-05-08

  The invention relates to new benzofuran derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds, and especially their use as anti-infectives.

  本发明涉及新的苯并呋喃衍生物及其在制备药物组成物中作为活性成分的用途。本发明还涉及相关方面，包括制备该化合物的过程、含有其中一种或多种化合物的药物组成物，尤其是它们作为抗感染剂的用途。
• Compounds for Treating Protein-Kinase Mediated Disorders
  申请人：Berdini Valerio

  公开号：US20080275029A1

  公开（公告）日：2008-11-06

  The invention provides a compound of the formula (I) or a salt, solvate, tautomer or N-oxide thereof for use in the treatment or prophylaxis of a disease state or condition mediated by protein kinase A and/or protein kinase B; wherein the ring Q is a benzene ring; J 2 -J 1 is N═CR 7 or R 1a N—CO; G is OH or NR 5 R 6 ; E is CONR 7 , NR 7 CO, C(R 8 )═C(R 8 ) or (X) m (CR 8 R 8a ) n where X is O, S or NR 7 ; provided that when J 2 -J 1 is R 1a N—CO, E is other than NR 7 CO; m and n are each 0 or 1, where m+n=1 or 2; A is a bond and R 4 and R 4a are absent or A is a saturated optionally substituted C 1-7 hydrocarbon linker group having a maximum chain length of 5 atoms extending between E and G, one carbon atom in the linker group A being optionally replaced by O or N; R 1 , R 1a , R 2 , and R 3 are each H; halogen; C 1-6 hydrocarbyl optionally substituted by halogen, OH or C 1-2 alkoxy; CN; CONHR 8 ; NH 2 ; NHCOR 10 or NHCONHR 10 ; R 4 is H or C 1-4 alkyl; R 4a is H, C 1-4 alkyl or a group R 9 ; R 5 and R 6 are each selected from H, R 9 and C 1-4 hydrocarbyl optionally substituted by halogen, C 1-2 alkoxy or R 9 ; or NR 5 R 6 forms a saturated 4-7 membered monocyclic heterocyclic group; R 7 is H or C 1-4 alkyl; R 8 and R 8a each H or saturated C 1-4 hydrocarbyl optionally substituted by fluorine; R 9 is a monocyclic or bicyclic carbocyclic or heterocyclic group containing up to 3 ring heteroatoms selected from N, O and S; or R 4 , R 4a and A together form a saturated monocyclic 4-7 membered heterocycle; or NR 5 R 6 , R 4 and A form a saturated 4-7 membered monocyclic heterocycle; or R 4 , together with R 7 or R 8 and A and E form a 4-7 membered saturated monocyclic heterocycle; or NR 5 R 6 and R 7 or R 8 together with A and E form a 4-7 membered saturated monocyclic heterocycle; and R 10 is optionally substituted phenyl or benzyl.

  该发明提供了一种式(I)的化合物或其盐、溶剂化物、互变异构体或N-氧化物，用于治疗或预防由蛋白激酶A和/或蛋白激酶B介导的疾病状态或病情；其中，环Q是苯环；J2-J1是N═CR7或R1aN—CO；G是OH或NR5R6；E是CONR7、NR7CO、C(R8)═C(R8)或(X)m(CR8R8a)n，其中X为O、S或NR7；但当J2-J1是R1aN—CO时，E为除NR7CO之外的其他化合物；m和n各为0或1，其中m+n=1或2；A是键，R4和R4a不存在或A是饱和的可选取代的C1-7烃链连接基，在E和G之间具有最大链长为5个原子，链连接基中的一个碳原子可被O或N取代；R1、R1a、R2和R3各为H、卤素、C1-6烃基，可选取代卤素、OH或C1-2烷氧基、CN、CONHR8、NH2、NHCOR10或NHCONHR10；R4为H或C1-4烷基；R4a为H、C1-4烷基或基团R9；R5和R6各为H、R9和C1-4烃基，可选取代卤素、C1-2烷氧基或R9；或NR5R6形成饱和的4-7成员的单环杂环基；R7为H或C1-4烷基；R8和R8a各为H或饱和的C1-4烃基，可选取代氟；R9为含有最多3个环杂原子（选自N、O和S）的单环或双环碳环或杂环基；或R4、R4a和A一起形成饱和的单环4-7成员杂环；或NR5R6、R4和A形成饱和的4-7成员单环杂环；或R4与R7或R8和A、E一起形成4-7成员饱和的单环杂环；或NR5R6与R7或R8一起与A和E形成4-7成员饱和的单环杂环；R10为可选取代苯基或苄基。
• Novel Oxadiazole Derivatives and Their Use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors
  申请人：Bugada Piergiuliano

  公开号：US20090197897A1

  公开（公告）日：2009-08-06

  The present invention relates to new compounds which are Oxadiazole derivatives of formula (I) wherein B, P, Q, W, R 1 and R 2 are defined in the description. Invention compounds are useful in the prevention or treatment of central or peripheral nervous system disorders as well as other disorders modulated by mGluR5 receptors.

  本发明涉及一种新的化合物，其为公式(I)的Oxadiazole衍生物，其中B、P、Q、W、R1和R2在说明中定义。本发明化合物在预防或治疗中枢或外周神经系统疾病以及其他受mGluR5受体调节的疾病中有用。
• Derivatives of 4-fluoroanthranilic acid and their use as fungicides
  申请人：SCHERING AGROCHEMICALS LIMITED

  公开号：EP0360417A2

  公开（公告）日：1990-03-28

  Compounds of formula I where A, B and R¹⁻⁶ are as defined in the description have pesticidal and especially fungicidal activity. Many of the compounds are novel and these compounds per se, form part of the invention.

  式 I 的化合物 其中 A、B 和 R¹-⁶ 如说明中所定义，具有杀虫特别是杀真菌活性。许多化合物都是新颖的，这些化合物本身就是本发明的一部分。